Ara
Toplam kayıt 3, listelenen: 1-3
The Approach to High Risk Bladder Cancers in the Absence of Bacillus Calmette Guerin: What should Be the Treatment and Follow Up?
(Galenos Yayincilik, 2014)
Bacillus Calmette Guerin (BCG), is the optimal bladder-sparing treatment option for patients with high-risk, non-muscle invasive bladder cancer. Recently, the application of BCG has been hindered due to the problem of its ...
Combination therapies for the management of nocturia and its comorbidities
(Dove Medical Press Ltd, 2015)
Nocturia is the most bothersome lower urinary tract symptom. It has a multifactorial etiology. It had been thought nocturia was a nonspecific symptom of lower urinary system dysfunction, but it has been determined that ...
Comparison of the Clinical and Pathologic Staging in Patients Undergoing Radical Cystectomy, the Factors Associated with Upstaging and its Effect on Outcome
(Galenos Yayincilik, 2014)
Bladder cancer is clinically understaged in about half of the cases and no improvements in solving this problem has been observed during the past 25 years. Patients who are clinically upstaged after radical cystectomy have ...